| Biomarker ID | 1123 |
| PMID | 23719956 |
| Year | 2013 |
| Biomarker | miR-24 |
| Biomarker Basis | Expression Based |
| Biomolecule | miRNA |
| Source | Serum |
| Subjects | Mice |
| Regulation | Upregulated in TRAMP Mice |
| Odds Ratio/Hazard Ratio/Relative Risk | NA |
| Effect on Pathways | Pathways Include:- intracellular membrane-bounded organelle; DNA-binding transcription factor activity, RNA polymerase II-specific; nuclear chromatin; intracellular organelle; nucleus |
| Experiment | TRansgenic Adenocarcinoma of Mouse Prostate (TRAMP) VS Wild Type (WT) mice |
| Type of Biomarker | Diagnostic |
| Cohort | 5 (TRansgenic Adenocarcinoma of Mouse Prostate (TRAMP) TRAMP and 5 Wild type mice were used for this study |
| Senstivity | NA |
| Specificity | NA |
| AUC | NA |
| Accuracy | NA |
| Level Of Significance | p < 0.01 |
| Method Used | Quantitative PCR |
| Clinical | No |
| Remarks | NA |
| Clinical Trial Number | NA |
| Degree Of Validity | Not validated on human patient cohort |
| Technical Name | miR-24 |